{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:17:10Z","timestamp":1792163830119,"version":"4.4.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2009 SGR 1022"],"award-info":[{"award-number":["2009 SGR 1022"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["AP2008-01923"],"award-info":[{"award-number":["AP2008-01923"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003176","name":"Ministerio de Educaci\u00f3n, Cultura y Deporte","doi-asserted-by":"publisher","award":["CM08\/00028"],"award-info":[{"award-number":["CM08\/00028"]}],"id":[{"id":"10.13039\/501100003176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP08\/00140"],"award-info":[{"award-number":["CP08\/00140"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI09\/1044"],"award-info":[{"award-number":["PI09\/1044"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jad.2011.10.015","type":"journal-article","created":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T17:47:07Z","timestamp":1321638427000},"page":"125-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["New treatment guidelines for acute bipolar mania: A critical review"],"prefix":"10.1016","volume":"140","author":[{"given":"Alessandra M.A.","family":"Nivoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Murru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Goikolea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Gonz\u00e1lez-Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paz","family":"Garc\u00eda-Portilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Bobes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f3nimo","family":"S\u00e1iz-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2011.10.015_bb0005","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.1994.03510360044034","article-title":"Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group","volume":"271","author":"Bowden","year":"1994","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.jad.2011.10.015_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0025","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.4088\/JCP.v67n1003","article-title":"A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania","volume":"67","author":"Bowden","year":"2006","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/YIC.0b013e3282fd827c","article-title":"A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode","volume":"23","author":"Bowden","year":"2008","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0030","series-title":"Proceedings of the 161th APA Conference, Washington, DC, May 3\u20138","article-title":"Efficacy and safety of asenapine as adjunctive treatment for acute mania associated with bipolar disorder","author":"Calabrese","year":"2008"},{"issue":"9799","key":"10.1016\/j.jad.2011.10.015_bb0035","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2011.10.015_bb0040","first-page":"184","article-title":"Effectiveness of extended release formulation of quetiapine as montherapy for the treatment of acute bipolar mania (trial D144CC00004)","volume":"11","author":"Cutler","year":"2008","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0045","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1017\/S0033291705005933","article-title":"Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project","volume":"35","author":"Dennehy","year":"2005","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.jad.2011.10.015_bb0050","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.euroneuro.2010.07.003","article-title":"A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007)","volume":"20","author":"El Mallakh","year":"2010","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2005.01.004","article-title":"Treatment guidelines for bipolar disorder: a critical review","volume":"86","author":"Fountoulakis","year":"2005","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1176\/ajp.149.1.108","article-title":"A double-blind comparison of valproate and lithium in the treatment of acute mania","volume":"149","author":"Freeman","year":"1992","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0075","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1371\/journal.pmed.0030319","article-title":"The newest mania: seeing disease mongering everywhere","volume":"3","author":"Ghaemi","year":"2006","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.jad.2011.10.015_bb0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1399-5618.2010.00861.x","article-title":"From BALANCE to DSM-5: taking lithium seriously","volume":"12","author":"Ghaemi","year":"2010","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1399-5618.2007.00556.x","article-title":"Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force Report","volume":"10","author":"Ghaemi","year":"2008","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0085","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4088\/JCP.09m05483yel","article-title":"Poor long-term prognosis in mixed bipolar patients: 10-year outcomes in the vitoria prospective naturalistic study in Spain","volume":"72","author":"Gonz\u00e1lez-Pinto","year":"2011","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1192\/bjp.164.2.149","article-title":"Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder","volume":"164","author":"Goodwin","year":"1994","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition \u2014 recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.euroneuro.2009.04.003","article-title":"Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice","volume":"19","author":"Goodwin","year":"2009","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/15622970309167904","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: treatment of mania","volume":"4","author":"Grunze","year":"2003","journal-title":"The World Journal of Biological Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World Journal of Biological Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of bipolar depression","volume":"11","author":"Grunze","year":"2010","journal-title":"The World Journal of Biological Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.euroneuro.2010.08.001","article-title":"2-year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery","volume":"21","author":"Haro","year":"2010","journal-title":"European Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.jad.2011.10.015_bb0125","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","article-title":"Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial","volume":"161","author":"Hirschfeld","year":"2004","journal-title":"Am. J. Psychiatry."},{"key":"10.1016\/j.jad.2011.10.015_bb0130","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1176\/appi.ajp.157.11.1873","article-title":"Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire","volume":"157","author":"Hirschfeld","year":"2000","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0140","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0150","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":"Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial","volume":"160","author":"Keck","year":"2003","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0135","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4088\/JCP.v67n0414","article-title":"A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder","volume":"67","author":"Keck","year":"2006","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study","volume":"112","author":"Keck","year":"2009","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0155","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.187.3.229","article-title":"Risperidone in the treatment of acute mania: double-blind, placebo-controlled study","volume":"187","author":"Khanna","year":"2005","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1399-5618.2006.00276.x","article-title":"Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials","volume":"8","author":"Kushner","year":"2006","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0165","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF03035131","article-title":"Limitations in randomised controlled trials evaluating drug effects in mania","volume":"251","author":"Licht","year":"2001","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"key":"10.1016\/j.jad.2011.10.015_bb0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0447.2009.01383.x","article-title":"Clinical practice recommendations for bipolar disorder","volume":"439","author":"Malhi","year":"2009","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jad.2011.10.015_bb0175","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1399-5618.2008.00611.x","article-title":"Reporting outcomes in clinical trials for bipolar disorder: a commentary and suggestions for change","volume":"10","author":"Martinez-Ar\u00e1n","year":"2008","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0180","first-page":"142","article-title":"A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania","volume":"57","author":"McElroy","year":"1996","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0185","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","article-title":"Quetiapine or haloperidol as monotherapy for bipolar mania: a 12-week, double-blind, randomised, parallel-group, placebocontrolled trial","volume":"15","author":"McIntyre","year":"2005","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2009.12.028","article-title":"Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial","volume":"122","author":"McIntyre","year":"2010","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0195","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00004714-200108000-00006","article-title":"A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania","volume":"21","author":"Meenhan","year":"2001","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0200","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0205","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eurpsy.2010.09.012","article-title":"When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations","volume":"26","author":"Murru","year":"2011","journal-title":"European Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0220","article-title":"Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care","volume":"38","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2006","journal-title":"NICE Clinical Guideline"},{"key":"10.1016\/j.jad.2011.10.015_bb0215","article-title":"Update 2009. Bipolar disorder. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care","volume":"38","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2009","journal-title":"NICE Clinical Guideline"},{"key":"10.1016\/j.jad.2011.10.015_bb0210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jad.2007.04.020","article-title":"Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial","volume":"105","author":"Niufan","year":"2008","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0225","first-page":"55","article-title":"New treatment guidelines for acute bipolar depression: a systematic review","volume":"126","author":"Nivoli","year":"2010","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0230","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1185\/030079906X167444","article-title":"Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians","volume":"23","author":"Perlis","year":"2007","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.jad.2011.10.015_bb0235","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.4088\/JCP.v67n1112","article-title":"Olanzapine versus risperidone in the treatment of manic or mixed states in bipolar I disorder: a randomized, double-blind trial","volume":"67","author":"Perlis","year":"2006","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0240","doi-asserted-by":"crossref","first-page":"509","DOI":"10.4088\/JCP.v67n0401","article-title":"Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials","volume":"67","author":"Perlis","year":"2006","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0245","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1991.01810250064008","article-title":"Valproate in the treatment of acute mania. A placebo-controlled study","volume":"48","author":"Pope","year":"1991","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0250","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.jcp.0000169068.34322.70","article-title":"Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial","volume":"25","author":"Potkin","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0255","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.pnpbp.2009.03.024","article-title":"Observational study designs for bipolar disorder \u2014 what can they tell us about treatment in acute mania?","volume":"15","author":"Reed","year":"2009","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0260","first-page":"CD004043","article-title":"Risperidone alone or in combination for acute mania","volume":"25","author":"Rendell","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jad.2011.10.015_bb0270","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1399-5618.2009.00698.x","article-title":"Clinical predictors of functional outcome of bipolar patients in remission","volume":"11","author":"Rosa","year":"2009","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0265","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4088\/JCP.09m05026gre","article-title":"Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study","volume":"71","author":"Rosa","year":"2010","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0280","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1176\/appi.ajp.159.7.1146","article-title":"Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety","volume":"159","author":"Sachs","year":"2002","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0275","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1399-5618.2004.00115.x","article-title":"Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, doubleblind, placebo-controlled study","volume":"6","author":"Sachs","year":"2004","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0285","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0290","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000228249","article-title":"Functioning and disability in bipolar disorder: an extensive review","volume":"78","author":"Sanchez-Moreno","year":"2009","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1016\/j.jad.2011.10.015_bb0295","first-page":"176","article-title":"Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial","volume":"21","author":"Segal","year":"1998","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0305","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.318.7183.593","article-title":"Clinical guidelines: developing guidelines","volume":"318","author":"Shekelle","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2011.10.015_bb0300","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1399-5618.2005.00186.x","article-title":"Quality of life for patients with bipolar disorder: relationship with clinical and demographic variables","volume":"7","author":"Sierra","year":"2005","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0310","first-page":"265","article-title":"Lithium combined with carbamazepine or haloperidol in the treatment of mania","volume":"31","author":"Small","year":"1995","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1016\/j.jad.2011.10.015_bb0315","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1399-5618.2007.00468.x","article-title":"Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials","volume":"9","author":"Smith","year":"2007","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0320","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2004.06.003","article-title":"Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol","volume":"15","author":"Smulevich","year":"2005","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0355","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"Tohen","year":"1999","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0360","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","article-title":"Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group","volume":"57","author":"Tohen","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0335","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.59.1.62","article-title":"Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy","volume":"59","author":"Tohen","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0345","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","article-title":"A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania","volume":"60","author":"Tohen","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0350","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1176\/appi.ajp.160.7.1263","article-title":"Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study","volume":"160","author":"Tohen","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0330","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1176\/appi.ajp.163.2.247","article-title":"Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine","volume":"163","author":"Tohen","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0325","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1192\/bjp.bp.107.041301","article-title":"Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes","volume":"192","author":"Tohen","year":"2008","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0365","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.4088\/JCP.v69n1113","article-title":"Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study","volume":"69","author":"Tohen","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0340","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1399-5618.2009.00726.x","article-title":"Task force report on the nomenclature of course and outcome in bipolar disorders","volume":"11","author":"Tohen","year":"2009","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0370","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1080\/15622970902840131","article-title":"New guidelines for bipolar disorders","volume":"10","author":"Vieta","year":"2009","journal-title":"The World Journal of Biological Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0375","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4088\/JCP.v64n1019a","article-title":"Divalproeax versus olanzapine in mania","volume":"64","author":"Vieta","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0395","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jad.2009.12.019","article-title":"Prevalence of mixed mania using 3 definitions","volume":"125","author":"Vieta","year":"2010","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0390","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.4088\/JCP.v65n1019","article-title":"Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data","volume":"65","author":"Vieta","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0400","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1399-5618.2005.00221.x","article-title":"A European perspective on the Canadian guidelines for bipolar disorder","volume":"7","author":"Vieta","year":"2005","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0405","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2007.05.009","article-title":"Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study","volume":"106","author":"Vieta","year":"2008","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0415","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: a placebo-controlled study","volume":"165","author":"Vieta","year":"2008","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0385","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-5618.2010.00815.x","article-title":"Randomised, placebo, active-controlled study of paliperidone extended-release (ER) for acute manic and mixed episodes in bipolar I disorder","volume":"12","author":"Vieta","year":"2010","journal-title":"European Neuropsychopharmacology Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0410","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0269881108099418","article-title":"Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study","volume":"24","author":"Vieta","year":"2010","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0425","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4088\/JCP.v65n0405","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes","volume":"65","author":"Weisler","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0435","first-page":"148","article-title":"Adjunctive ziprasidone in bipolar mania: short- and long-term data","volume":"55","author":"Weisler","year":"2004","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0430","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4088\/JCP.v66n0308","article-title":"Extended-release carbamazepine capsules as the WFSBP guidelines for the biological treatment of bipolar disorders 31 monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"66","author":"Weisler","year":"2005","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0440","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jad.2006.08.017","article-title":"Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004","volume":"99","author":"Wolfsperger","year":"2007","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0445","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1192\/bjp.182.2.141","article-title":"Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial","volume":"182","author":"Yatham","year":"2003","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0450","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5618.2005.00219.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies","volume":"7","author":"Yatham","year":"2005","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0455","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1399-5618.2006.00432.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007","volume":"8","author":"Yatham","year":"2006","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0465","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/YIC.0b013e328080ca57","article-title":"A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania","volume":"22","author":"Yatham","year":"2007","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0460","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-5618.2009.00672.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009","volume":"11","author":"Yatham","year":"2009","journal-title":"Bipolar Disorders"},{"key":"10.1016\/j.jad.2011.10.015_bb0470","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/npp.2010.192","article-title":"Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials","volume":"36","author":"Yildiz","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2011.10.015_bb0475","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.bp.108.049965","article-title":"Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study","volume":"194","author":"Young","year":"2009","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0480","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4088\/JCP.v63n1210","article-title":"A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder","volume":"63","author":"Zajecka","year":"2002","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jad.2011.10.015_bb0485","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/JCP.0b13e318033bd5e","article-title":"Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole","volume":"27","author":"Zimbroff","year":"2007","journal-title":"Journal of Clinical Psychopharmacology"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032711006598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032711006598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:10:24Z","timestamp":1759021824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032711006598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0165032711006598"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2011.10.015","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New treatment guidelines for acute bipolar mania: A critical review","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2011.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}